Valsartan and hydrochlorothiazide USP

(Diovan HCT®)

Valsartan and hydrochlorothiazide USP

Drug updated on 10/23/2023

Dosage FormTablet (oral; valsartan/HCTZ: 80 mg /12.5 mg, 160 mg /12.5 mg, 160 mg /25 mg, 320 mg /12.5 mg, 320 mg /25 mg)
Drug ClassMultiple
Ongoing and
Completed Studies
ClinicalTrials.gov

Indication

  • For the treatment of hypertension, to lower blood pressure in patients not adequately controlled with monotherapy.
  • For the treatment of hypertension as initial therapy in patients likely to need multiple drugs to achieve their blood pressure goals.

Product Monograph / Prescribing Information

Document TitleYearSource
Diovan HCT (valsartan and hydrochlorothiazide USP) Prescribing Information.2011Novartis Pharmaceuticals Corporation East Hanover, NJ